Skip to main content
. 2020 Mar 20;56(1):105949. doi: 10.1016/j.ijantimicag.2020.105949

Fig. 1.

Fig. 1

Percentage of patients with PCR-positive nasopharyngeal samples from inclusion to day6 post-inclusion in COVID-19 patients treated with hydroxychloroquine and in COVID-19 control patients.